Principal Scientist Ii
Currento Lead, developed and performed studies designed to elucidate target biology in vitro and in vivo in order to stratify patient populations, identify pharmacodynamic markers for potential clinical assays, and identify nodes of resistance/synergy/synthetic lethalityo Utilized genetic (CRISPR-Cas9/siRNA/shRNA/cDNA over-expression) means along with.